Catalent – Page 2 – Talk Bio

Actionable Insights Powered by AI

Catalent Reports Strong Q4 Results Amid Pending Acquisition by Novo Holdings

1 year ago talkbio0Tagged Acquisition (action), biotech, Catalent, Consumer health, Dosage Forms, Holdings, Q4, results

Catalent, Q4 Results, Novo Holdings, Acquisition, Pharmaceutical, Biotech, Consumer Health

Catalent’s Revival: Are the Dark Days Behind It Ahead of Novo Holdings Acquisition?

1 year ago talkbio0Tagged Acquisition (action), Catalent, day, Drug Industry, Holdings, Revival

Catalent, Novo Holdings, acquisition, pharmaceutical industry, revenue boost, dark days, revival

Catalent’s Joining the Novo Family Concurrent with Dampened COVID Sales Slide

2 years ago talkbio0Tagged Catalent, Catalent's

Catalent, Catalent’s